BRCA2 and ovarian cancer: Unlike most BRCA2 truncating variants that confer a high risk of breast and ovarian cancers [21], the BRCA2 p.K3326* mutation is regarded as a low-penetrant susceptibility allele for these hormone-related cancers [22–24].